Point72 Asia (Singapore)’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-3,794
Closed -$19.7K 1297
2024
Q3
$19.7K Buy
+3,794
New +$19.7K ﹤0.01% 818